News

Burrill & Company Leads $12.9 Million Series E Round In WhiteGlove Health April 16, 2012 | Press Release

Burrill & Company Leads $16.5 Million Round in WaveTec Vision to Commercialize Its Cataract Surgery Breakthrough April 16, 2012 | Press Release

Burrill & Company Leads ADMA Biologics’ $17.5 Million Private Placement April 15, 2012 | Press Release

  See all News
 
Sign up to receive email notifications about our upcoming events and news.


Burrill Venture Capital



Burrill Venture Capital actively seeks investment opportunities outside of the United States. We invest in life science companies whose technologies and products are principally focused on improvements in human healthcare.


Learn more about Burrill Venture Capital

International Merchant Banking

Burrill Merchant Banking advises life science companies on cross-border transactions, including M&A, strategic partnerships, spin-outs, private placements,and strategic development. 


Learn more about Burrill Merchant Banking

International Conferences



Burrill conferences examine the world of the life sciences from a global perspective.


See all upcoming Burrill Conferences